Evidence map›Paper›PMID 30547291›Full record

ArticlePathology oncology research : POR2019

Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response.

Soroush Nasri, Bostjan Humara, Ahmad Anjomshoaa, Nourodin Moradi, Naghmeh Gholipour, Sakineh Mashjoor, Peng Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Soroush NasriCancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box: 56, Dunedin, 9054, New Zealand.
Bostjan HumaraCancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box: 56, Dunedin, 9054, New Zealand.
Ahmad AnjomshoaaCancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box: 56, Dunedin, 9054, New Zealand.
Nourodin MoradiMilad Center for Medical Genetics, P.O. Box: 48156-59176, Sari, Iran.
Naghmeh GholipourMilad Center for Medical Genetics, P.O. Box: 48156-59176, Sari, Iran. ngholipour@nigeb.ac.ir.
Sakineh MashjoorDepartment of Marine biology, Faculty of Marine Science and Technology, Hormozgan University, P.O. Box: 3995, Bandar Abbas, Iran.
Peng ZhangDivision of Biomedical Science and Biochemistry, Research School of Biology, ANU College of Medicine, Biology and Environment, Australian National University, P.O. Box: 2601, Canberra, Australia.
Milad Hospital · IRAustralian National University · AUHormozgan University · IRKerman University of Medical Sciences · IRUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse gastric cancer (DGC) is one of the two primary types of stomach cancer. Carriers of germline mutations in the gene encoding E-cadherin are predisposed to DGC. The primary aim of the present study was to determine if genomic instability is an early event in DGC and how it may lead to disease progression. Chromosomal aberrations in early intramucosal hereditary diffuse gastric cancer (eHDGC) were assessed using array comparative genomic hybridization (array CGH). Notably, no aneuploidy or other large-scale chromosomal rearrangements were detected. Instead, all aberrations affected small regions (< 4.8 Mb) and were predominantly deletions. Analysis of DNA sequence patterns revealed that essentially all aberrations possessed the characteristics of common fragile sites. These results and the results of subsequent immunohistochemical examinations demonstrated that unlike advanced DGC, eHDGCs is characterized by low levels of genomic instability at fragile sites. Furthermore, they express an active DNA damage response, providing a molecular basis for the observed indolence of eHDGC. This finding is an important step to understanding the pathology underlying natural history of DGC and supports a revision of the current definition of eHDGC as a malignant disease.

Indexed as

Antigens, CDCadherinsDNA DamageGenetic Predisposition to DiseaseGenomic InstabilityGerm-Line MutationHumansStomach NeoplasmsAntigens, CDCadherinsCDH1 protein, humanArray CGHDiffuse gastric cancerDNA fragilityGenomic instability

Identifiers

PMID30547291
OpenAlexW2905183577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.